MDM4 and hepatocellular carcinoma: Additionally, another study listed in the TCGA’s database suggested that amplification of mouse double minute 4 (MDM4) is an important genetic change in the development of hepatocellular carcinoma (HCC), and a drug targeting this amplification has been undergoing clinical trials [7].